ACELYRIN, INC. Announces Launch of IPO Roadshow

LOS ANGELES, May 1, 2023 /PRNewswire/ — ACELYRIN, INC., a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced it has launched a roadshow for an initial public offering (IPO) of 20,600,000…